12601538

Source:http://linkedlifedata.com/resource/pubmed/id/12601538

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008838, umls-concept:C0031809, umls-concept:C0246415, umls-concept:C1335475, umls-concept:C1521750
pubmed:issue	1
pubmed:dateCreated	2003-2-25
pubmed:abstractText	Docetaxel (Taxotere) and cisplatin are two of the most active single agents used in the treatment of solid tumors. We examined the feasibility of using a combination of docetaxel and cisplatin for the treatment of unknown primary carcinoma in order to prepare a larger scale prospective study.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9616295
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1341-9625
pubmed:author	pubmed-author:AndoMasashiM, pubmed-author:KatsumataNoriyukiN, pubmed-author:MukaiHirofumiH, pubmed-author:WatanabeToruT
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	23-5
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:12601538-Adolescent, pubmed-meshheading:12601538-Adult, pubmed-meshheading:12601538-Aged, pubmed-meshheading:12601538-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12601538-Carcinoma, pubmed-meshheading:12601538-Cisplatin, pubmed-meshheading:12601538-Diarrhea, pubmed-meshheading:12601538-Drug Hypersensitivity, pubmed-meshheading:12601538-Feasibility Studies, pubmed-meshheading:12601538-Female, pubmed-meshheading:12601538-Humans, pubmed-meshheading:12601538-Male, pubmed-meshheading:12601538-Middle Aged, pubmed-meshheading:12601538-Nausea, pubmed-meshheading:12601538-Neoplasms, Unknown Primary, pubmed-meshheading:12601538-Neutropenia, pubmed-meshheading:12601538-Paclitaxel, pubmed-meshheading:12601538-Patient Compliance, pubmed-meshheading:12601538-Prospective Studies, pubmed-meshheading:12601538-Severity of Illness Index, pubmed-meshheading:12601538-Taxoids, pubmed-meshheading:12601538-Treatment Outcome, pubmed-meshheading:12601538-Vomiting
pubmed:year	2003
pubmed:articleTitle	Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel.
pubmed:affiliation	Department of Medical Oncology, National Cancer Center Hospital, 5-5-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. twatanab@ncc.go.jp
pubmed:publicationType	Journal Article, Evaluation Studies